New study to see if suctioning out blood clots beats standard care for deep vein thrombosis
NCT ID NCT07573618
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments for acute deep vein thrombosis (DVT) in the leg. Half of the 104 participants will receive standard blood-thinning medication alone, while the other half will also undergo a procedure to suction out the clot, sometimes with balloon dilation or a stent. Researchers will follow patients for 24 months to see which group has fewer complications like clot recurrence, lung clots, or long-term leg damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
thrombus aspiration procedure
What this could lead to
If successful, this could offer a more effective way to treat deep vein thrombosis and reduce long-term complications like post-thrombotic syndrome.
What could go wrong
This is a relatively small trial (104 people) and has not started recruiting yet. The procedure carries risks like bleeding or vessel damage, and it may not prove better than standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTTHROMBOTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.